Small Swedish biotech companies often have a business model of selling their research and drug candidates to larger pharmaceutical companies through licensing – a strategy that has become more important as the interest from investors seems to have cooled somewhat in recent years.
The purpose is to bring in capital, get help to finance the clinical...
The art of successful licensing – “A lot has to align”
Sharp research, strong data and a high level of innovation are all very good, but more than that is required to achieve the goal of many biotechnology companies: to succeed with a licensing deal.
Vill du få åtkomst till allt?
Prova 30 dagar för 0 kr.
Inga bindningstider eller kortuppgifter krävs.
Prova nu
Köp en prenumeration
Utforska våra prenumerationslösningar och välj den som passar dina behov.
Välj din prenumeration